Χώρα: Ηνωμένες Πολιτείες
Γλώσσα: Αγγλικά
Πηγή: NLM (National Library of Medicine)
Dextrose hydrous (UNII: LX22YL083G) (dextrose - UNII:IY9XDZ35W2), Sodium Chloride (UNII: 451W47IQ8X) (Sodium Chloride - UNII:451W47IQ8X), Potassium Chloride (UNII: 660YQ98I10) (Potassium Chloride - UNII:660YQ98I10), Magnesium Chloride (UNII: 02F3473H9O) (Magnesium Chloride - UNII:02F3473H9O), Sodium Gluconate (UNII: R6Q3791S76) (sodium gluconate - UNII:R6Q3791S76), Sodium Acetate (UNII: 4550K0SC9B) (sodium acetate - UNII:4550K0SC9B)
Baxter Healthcare Corporation
Sodium chloride, potassium chloride, calcium chloride, sodium gluconate, sodium acetate and dextrose
INJECTION, SOLUTION
5 g in 100 mL
INTRAVENOUS
PRESCRIPTION DRUG
Plasma-Lyte® 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) is indicated as a source of water, electrolytes, and calories, or as an alkalinizing agent. Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products.
Plasma-Lyte® 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) in Viaflex® plastic containers is available as shown below: Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25°C); brief exposure up to 40°C does not adversely affect the product.
PLASMA-LYTE 148 AND DEXTROSE- SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE AND DEXTROSE INJECTION, SOLUTION BAXTER HEALTHCARE CORPORATION ---------- PLASMA-LYTE® 148 AND 5% DEXTROSE INJECTION (MULTIPLE ELECTROLYTES AND DEXTROSE INJECTION, TYPE 1, USP) IN VIAFLEX® PLASTIC CONTAINER DESCRIPTION Plasma-Lyte® 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment and caloric supply in a single dose container for intravenous administration. Each 100 mL contains 5 g Dextrose Hydrous, USP*, 526 mg Sodium Chloride, USP (NaCl); 502 mg Sodium Gluconate (C H NaO ); 368 mg Sodium Acetate Trihydrate, USP (C H NaO •3H O), 37 mg Potassium Chloride, USP (KCl); and 30 mg Magnesium Chloride, USP (MgCl •6H O). It contains no antimicrobial agents. The pH is 5.0 (4.0 to 6.5). The pH is adjusted with hydrochloric acid. Plasma-Lyte® 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) administered intravenously has value as a source of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate and 23 mEq gluconate. The osmolarity is 547 mOsmol/L (calc). Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions (≥ 600 mOsmol/L) may cause vein damage. The caloric content is 190 kcal/L. The Viaflex® plastic container is fabricated from a specially formulated polyvinyl chloride (PL 146® Plastic). The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. CLINICAL PHARMACOLOGY Plasma Διαβάστε το πλήρες έγγραφο